Investigation of the Antitumor Effect of Targeting PI3K-AKT-mTOR Pathway and Histone Deacetylase Enzymes on Acute Myeloid Leukemia Cells

dc.contributor.author Sansacar, Merve
dc.contributor.author Sagir, Helin
dc.contributor.author Akcok, Emel Gencer
dc.contributor.department AGÜ, Yaşam ve Doğa Bilimleri Fakültesi, Biyomühendislik Bölümü en_US
dc.contributor.institutionauthor Sansacar, Merve
dc.contributor.institutionauthor Sagir, Helin
dc.contributor.institutionauthor Akcok, Emel Gencer
dc.date.accessioned 2021-11-27T08:57:45Z
dc.date.available 2021-11-27T08:57:45Z
dc.date.issued 2021 en_US
dc.description.abstract Investigation of the Antitumor Effect of Targeting PI3K-AKT-mTOR Pathway and Histone Deacetylase Enzymes on Acute Myeloid Leukemia Cells en_US
dc.identifier.issn 2152-2650
dc.identifier.issn 2152-2669
dc.identifier.uri https://hdl.handle.net/20.500.12573/1045
dc.identifier.volume Volume 21 Page S294-S294 Supplement 1 Meeting Abstract AML-240 en_US
dc.language.iso eng en_US
dc.publisher CIG MEDIA GROUP, LP3500 MAPLE AVENUE, STE 750, DALLAS, TX 75219-3931 en_US
dc.relation.journal CLINICAL LYMPHOMA MYELOMA & LEUKEMIA en_US
dc.relation.publicationcategory Konferans Öğesi - Uluslararası - Başka Kurum Yazarı en_US
dc.rights info:eu-repo/semantics/closedAccess en_US
dc.subject AML en_US
dc.subject acute myeloid leukemia en_US
dc.subject PI3K/AKT/mTOR pathway en_US
dc.subject histone deacetylase inhibitors en_US
dc.subject HDAC inhibitors en_US
dc.subject combination therapy en_US
dc.title Investigation of the Antitumor Effect of Targeting PI3K-AKT-mTOR Pathway and Histone Deacetylase Enzymes on Acute Myeloid Leukemia Cells en_US
dc.type conferenceObject en_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.44 KB
Format:
Item-specific license agreed upon to submission
Description: